Altered cofactor binding affects stability and activity of human UDP-galactose 4′-epimerase: Implications for type III galactosemia

Autor: Judith L. Fridovich-Keil, Tyler J. Gleason, David J. Timson, Ying Liu, Thomas J. McCorvie, Andrew Frazer
Jazyk: angličtina
Předmět:
Galactosemias
Models
Molecular

Protein Denaturation
UDP-galactose 4′-epimerase
Coenzymes
Type III galactosemia
Biology
Cofactor
Article
Protein Structure
Secondary

Fungal Proteins
03 medical and health sciences
Structure-Activity Relationship
UDPglucose 4-Epimerase
Protein structure
Yeasts
medicine
Escherichia coli
Humans
Disease-associated mutation
Molecular Biology
Alleles
030304 developmental biology
Yeast model
chemistry.chemical_classification
0303 health sciences
Cofactor binding
Uridine Diphosphate N-Acetylglucosamine
030302 biochemistry & molecular biology
Galactosemia
Galactose
medicine.disease
NAD
Molecular biology
Yeast
Recombinant Proteins
GALE
Kinetics
Enzyme
chemistry
Biochemistry
Differential scanning fluorimetry
biology.protein
Molecular Medicine
Salt bridge
NAD+ kinase
Protein Multimerization
Peptide Hydrolases
Protein Binding
Zdroj: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. (10):1516-1526
ISSN: 0925-4439
DOI: 10.1016/j.bbadis.2012.05.007
Popis: Deficiency of UDP-galactose 4′-epimerase is implicated in type III galactosemia. Two variants, p.K161N-hGALE and p.D175N-hGALE, have been previously found in combination with other alleles in patients with a mild form of the disease. Both variants were studied in vivo and in vitro and showed different levels of impairment. p.K161N-hGALE was severely impaired with substantially reduced enzymatic activity, increased thermal stability, reduced cofactor binding and no ability to rescue the galactose-sensitivity of gal10-null yeast. Interestingly p.K161N-hGALE showed less impairment of activity with UDP-N-acetylgalactosamine in comparison to UDP-galactose. Differential scanning fluorimetry revealed that p.K161N-hGALE was more stable than the wild-type protein and only changed stability in the presence of UDP-N-acetylglucosamine and NAD+. p.D175N-hGALE essentially rescued the galactose-sensitivity of gal10-null yeast, was less stable than the wild-type protein but showed increased stability in the presence of substrates and cofactor. We postulate that p.K161N-hGALE causes its effects by abolishing an important interaction between the protein and the cofactor, whereas p.D175N-hGALE is predicted to remove a stabilizing salt bridge between the ends of two α-helices that contain residues that interact with NAD+. These results suggest that the cofactor binding is dynamic and that its loss results in significant structural changes that may be important in disease causation.
Databáze: OpenAIRE